AbbVie's First Quarter: Can We Quit Worrying About Humira Now?
It looks like the fortress AbbVie Inc.'s lead drug built will be able to stand on its own soon.
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment